Transcutaneous Stimulation for Spina Bifida

This trial explores whether transcutaneous spinal cord stimulation, which uses electrical currents applied through the skin to stimulate the spinal cord, can enhance leg muscle strength and walking ability in children with myelomeningocele, a type of spina bifida. The researchers aim to determine if this treatment can improve walking, even with assistance or devices. It suits children diagnosed with myelomeningocele who experience some difficulty walking and have a stable bladder management routine. As an unphased trial, this study provides a unique opportunity for children to potentially benefit from an innovative treatment approach.

The trial protocol does not specify whether you need to stop taking your current medications. However, you must be on a stable bladder management regimen for at least 4-6 weeks before joining the trial.

Research has shown that transcutaneous spinal cord stimulation (tSCS) is safe and well-tolerated in children with spina bifida. In earlier studies, children who received this treatment did not experience negative side effects. Some children even reported almost complete pain relief and improved movement abilities without issues. Other research supports the safety of this method, noting its successful use in adults with spinal cord injuries to enhance muscle strength and control, again without harmful side effects. Overall, the evidence suggests that tSCS is a promising and safe option for managing spina bifida symptoms in children.¹²³⁴⁵

Unlike the standard care options for spina bifida, such as surgery or physical therapy, Transcutaneous Spinal Cord Stimulation (tSCS) offers a non-invasive approach that stands out. This treatment works by delivering electrical currents through the skin to stimulate the spinal cord, potentially enhancing nerve function and mobility without the need for surgery. Researchers are excited about tSCS because it could offer a safer and more accessible alternative, with less recovery time and fewer risks, providing new hope for improved quality of life for those with spina bifida.

Studies have shown that transcutaneous spinal cord stimulation (tSCS), which sends electrical signals through the skin to the spinal cord, may improve leg muscle function and walking speed in people with spinal cord injuries. In children with spina bifida, tSCS has effectively improved movement, sensation, and bladder issues. Research in both adults and children suggests that this non-invasive method can enhance motor control, helping people move their muscles better. Although more research is needed specifically for spina bifida, these findings suggest that tSCS could improve mobility and strength in affected children. This trial will provide all participants with transcutaneous spinal cord stimulation to evaluate its effectiveness further.²³⁴⁶⁷